Most healthcare professionals will advise you to do everything in your power to lose weight ... drugs have been approved by the U.S. Food and Drug Administration only for use in people with ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

A new study funded by Eli Lilly reports that people without diabetes can lose up to 13% of their starting ... “And what ...

At 289 pounds, he had struggled to lose weight ... while using Ozempic as directed by her physicians to manage her Type 2 Diabetes last year. She was not on the medication for weight loss and ...

The class of weight-loss drugs ... a company using health care data to inform health economics research, monitor safety and support clinical trials. People without type 2 diabetes have a harder ...

However, people using metformin for its FDA-approved use may lose weight as a side effect. The exact mechanism of why weight loss may occur is unclear. Unlike other diabetes medications ...

Drugs like Wegovy and Zepbound have been a godsend for people struggling with obesity, diabetes and other life ... Some patients are losing too much weight. Here & Now's Peter O'Dowd speaks ...

Yet federal regulators recently declared the blockbuster weight-loss drugs Wegovy and Zepbound are no longer in shortage. That means consumers who use telehealth ... to treat diabetes and Zepbound ...